Handelsbanken Fonder Portfolio holdings
AUM
$28.2B
1-Year Return
24.55%
This Quarter Return
+2.37%
1 Year Return
+24.55%
3 Year Return
+103.92%
5 Year Return
+192.89%
10 Year Return
–
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.04B
Cap. Flow
% of AUM
3.97%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| 1 |
Microsoft
MSFT
|
+$106M |
| 2 |
EXL Service
EXLS
|
+$73.9M |
| 3 |
Apple
AAPL
|
+$68.3M |
| 4 |
ServiceNow
NOW
|
+$57.4M |
| 5 |
Synopsys
SNPS
|
+$52.8M |
Top Sells
| 1 |
Halozyme
HALO
|
+$69.5M |
| 2 |
Edwards Lifesciences
EW
|
+$47.6M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$46.5M |
| 4 |
Rockwell Automation
ROK
|
+$40.5M |
| 5 |
Abbott
ABT
|
+$39.4M |
Sector Composition
| 1 | Technology | 37.43% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.03% |
| 4 | Communication Services | 9.46% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Revolve Group
RVLV
$1.65B
| $546K | ﹤0.01% |
16,300
| – | – |
|
1252
Aurinia Pharmaceuticals
AUPH
$1.63B
| $545K | ﹤0.01% |
60,700
| – | – |
|
1253
Iovance Biotherapeutics
IOVA
$829M
| $538K | ﹤0.01% |
72,700
-2,100
| -3% | -$15.5K |
|
1254
UFP Technologies
UFPT
$1.53B
| $538K | ﹤0.01% |
+2,200
| New | +$538K |
|
1255
Clarivate
CLVT
$2.89B
| $537K | ﹤0.01% |
105,700
-8,400
| -7% | -$42.7K |
|
1256
Amphastar Pharmaceuticals
AMPH
$1.35B
| $535K | ﹤0.01% |
14,400
-2,500
| -15% | -$92.9K |
|
1257
Integra LifeSciences
IART
$1.17B
| $535K | ﹤0.01% |
23,602
| – | – |
|
1258
ADT
ADT
$7B
| $534K | ﹤0.01% |
77,300
+400
| +0.5% | +$2.76K |
|
1259
Celldex Therapeutics
CLDX
$1.63B
| $533K | ﹤0.01% |
21,100
+7,300
| +53% | +$184K |
|
1260
Green Brick Partners
GRBK
$3.18B
| $531K | ﹤0.01% |
9,400
+400
| +4% | +$22.6K |
|
1261
Dyne Therapeutics
DYN
$1.9B
| $530K | ﹤0.01% |
22,500
+3,200
| +17% | +$75.4K |
|
1262
Victory Capital Holdings
VCTR
$4.76B
| $530K | ﹤0.01% |
8,100
+1,600
| +25% | +$105K |
|
|
HTO
1263
H2O America Common Stock
HTO
$1.74B
| $527K | ﹤0.01% |
10,704
-216
| -2% | -$10.6K |
|
1264
Criteo
CRTO
$1.23B
| $526K | ﹤0.01% |
13,300
| – | – |
|
|
DEA
1265
Easterly Government Properties
DEA
$1.04B
| $526K | ﹤0.01% |
18,520
+7,400
| +67% | +$210K |
|
1266
Bausch Health
BHC
$2.68B
| $525K | ﹤0.01% |
65,100
+10,100
| +18% | +$81.5K |
|
1267
Premier
PINC
$2.22B
| $524K | ﹤0.01% |
24,695
-16,600
| -40% | -$352K |
|
1268
Tecnoglass
TGLS
$3.36B
| $524K | ﹤0.01% |
6,600
| – | – |
|
1269
Vestis
VSTS
$543M
| $520K | ﹤0.01% |
+34,100
| New | +$520K |
|
1270
Immunovant
IMVT
$2.9B
| $518K | ﹤0.01% |
20,900
| – | – |
|
1271
Ultra Clean Holdings
UCTT
$1.12B
| $518K | ﹤0.01% |
14,400
-3,800
| -21% | -$137K |
|
1272
Atlanta Braves Holdings Series B
BATRK
$2.63B
| $516K | ﹤0.01% |
13,477
-900
| -6% | -$34.5K |
|
1273
CleanSpark
CLSK
$2.82B
| $516K | ﹤0.01% |
56,000
| – | – |
|
1274
First Financial Bancorp
FFBC
$2.45B
| $516K | ﹤0.01% |
19,184
| – | – |
|
1275
Upwork
UPWK
$2.09B
| $515K | ﹤0.01% |
31,500
-8,700
| -22% | -$142K |
|